{"id":"W3169203421","doi":"10.1200/jco.2021.39.15_suppl.tps4164","title":"Phase III study of NUC-1031 + cisplatin versus gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Gemcitabine; Medicine; Tolerability; Cisplatin; Regimen; Internal medicine; Oncology; Cancer; Phases of clinical research; Population; Chemotherapy; Gastroenterology; Pharmacology; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015394,0.00145052,0.00253232,0.0005203084,0.0003777953,0.0008834931,0.001033949,0.00129529,0.005204248],"category_scores_gemma":[0.0009630503,0.0007238052,0.001227434,0.000453019,0.0007890753,0.0007984107,0.0004282327,0.002743721,0.001239984],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001102299,"about_ca_system_score_gemma":0.00205076,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001391656,"about_ca_topic_score_gemma":0.003896347,"domain_scores_codex":[0.9995977,0.0002302878,0.00001872929,0.00005445904,0.00003450842,0.00006425869],"domain_scores_gemma":[0.9993124,0.0000983369,0.0001158229,0.00006333891,0.00004693846,0.0003631995],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7665525,0.08366747,0.00518408,0.0009016853,0.001226637,0.0002001895,0.0002750376,0.002980113,0.0376194,0.0003532138,0.004186246,0.09685344],"study_design_scores_gemma":[0.4453009,0.5388404,0.007462466,0.00003706858,0.0004137001,0.0002737206,0.00005156628,0.001644805,0.003652016,0.0001652495,0.002130188,0.00002785333],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908275,0.001394579,0.0004805319,0.0003728048,0.0001613222,0.003373341,0.001188141,0.000131142,0.00207074],"genre_scores_gemma":[0.9836157,0.002008304,0.002581387,0.0006727057,0.0001657954,0.003921115,0.002941948,0.00005205571,0.004040966],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005204248,"threshold_uncertainty_score":0.01740998,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1383867645147306,"score_gpt":0.4770054619385265,"score_spread":0.3386186974237959,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}